| CD10
|
B-E3
|
854.090.000 |
Cytotoxic In association with rabbit complement on CD10+ cells
|
| CD102
|
B-T1
|
852.760.000 |
Inhibits cell adhesion and T-cell activation
|
| CD106 / VCAM-1
|
B-K9
|
852.770.000 |
Inhibits cell attachment to VCAM-1
|
| CD117 / c-kit
|
B-K15
|
854.510.000 |
Inhibits the KIT ligand induced proliferation of TF1 cell line
|
| CD126 / IL-6R
|
B-R6
|
852.030.000 |
Inhibits IL-6 induced proliferation of XG-1 cells
|
| CD130 / gp130
|
B-S12
|
852.110.000 |
Activates cells carrying gp130. Induces gp130 activation, Jak 1, Jak 2, Stat 1 and Stat 3 phosphorylation
|
| CD130 / gp130
|
B-P4
|
852.090.000 |
Inhibits IL-11 activity and binding to gp130, but not CNTF, LIF and OSM activities
|
| CD130 / gp130
|
B-P8
|
852.080.000 |
Inhibits CNTF activity and binding to gp130. Induces gp130 activation, Jak 1, Jak 2, Stat 1 and Stat 3 phosphorylation
|
| CD130 / gp130
|
B-K5
|
852.070.000 |
Inhibits CNTF activity. Inhibits OSM binding to gp130
|
| CD130 / gp130
|
B-R3
|
852.060.000 |
Inhibits IL-6, IL-11, CNTF, LIF and OSM activities
|
| CD178/FasL
|
B-R17
|
853.070.000 |
Inhibits soluble CD178 induced apoptosis
|
| CD184
|
B-R24
|
854.600.000 |
Inhibits HIV-1 infection
|
| CD2 / LFA-2
|
B-E2
|
852.500.000 |
Inhibits mixed lymphocyte culture
|
| CD20
|
B-H20
|
854.150.000 |
Cytotoxic in association with complement on CD20 cells
|
| CD202b / Tie-2 / TEK
|
B-B48
|
854.710.000 |
Inhibits Tek-L / Tek binding
|
| CD21
|
B-E5
|
854.160.000 |
Induces human B-cell proliferation and competes with EBV for CD21 binding
|
| IL-18Ra
|
B-E43
|
854.900.000 |
Inhibits human IFNγ secretion induced by IL-18 stimulated cells
|
| IL-18Rb
|
B-B46
|
854.910.000 |
Inhibits human IFNγ secretion induced by IL-18 stimulated cells
|
| CD25 / IL-2R
|
B-B10
|
852.000.000 |
Inhibits mixed lymphocyte culture
|
| CD25 / IL-2R
|
B-F2
|
852.010.000 |
Inhibits mixed lymphocyte culture
|
| TRAIL
|
B-S23
|
853.080.000 |
Enhances TRAIL induced apoptosis
|
| TRAIL / APO2L
|
B-T24
|
853.090.000 |
Inhibits TRAIL induced apoptosis
|
| TRAIL R1 / DR4
|
B-N36
|
854.850.000 |
Neutralizes TRAIL induced apoptosis on HEL cell line
|
| TRAIL R2 / DR5
|
B-D37
|
854.870.000 |
Agonist: induced apoptosis on Jurkat cells. Enhances TRAIL induced apoptosis of U937 cell line
|
| TRAIL R2 / DR5
|
B-K29
|
854.860.000 |
Neutralizes TRAIL induced apoptosis of U937 cell line
|
| TRAIL R3 / DcR1
|
B-D44
|
854.890.000 |
Inhibits TRAIL binding to TRAIL R3
|
| CD28
|
B-T3
|
854.220.000 |
Inhibits mixed lymphocyte culture. Co-stimulates T-cell proliferation.
|
| CD3
|
B-B11
|
854.010.000 |
Induces T lymphocyte stimulation and proliferation
|
| CD34 Class I
|
B-G25
|
854.240.000 |
Triggers KG-1a cell aggregation
|
| CD4
|
B-A1
|
854.030.000 |
Inhibits mixed lymphocyte culture
|
| CD40
|
B-B20
|
854.280.000 |
Stimulates B-cell proliferation together with IL-4
|
| CD44 / PGP-1
|
B-F24
|
852.600.000 |
Triggers T-lymphocyte aggregation. Enhances Hyaluronan binding to CD44
|
| CD54
|
B-H17
|
852.690.000 |
Inhibits PHA stimulated T-cell proliferation
|
| CD86
|
B-T7
|
854.450.000 |
Inhibits mixed lymphocyte culture
|
| CD95 / FAS
|
B-D29
|
853.030.000 |
Inhibits FasL induced apoptosis
|
| CD95 / FAS
|
B-G27
|
853.000.000 |
Triggers Fas induced apoptosis
|
| HLA Class I
|
W6/32
|
857.220.000 |
Inhibits the interaction between T cells and MHC molecules
|
| IFN-γ
|
B-B1
|
855.000.000 |
Inhibits IFNγ induced proliferation
|
| IL-10
|
B-S10
|
855.100.000 |
Blocks IL-10 induced inhibition of IL-6 synthesis on LPS activated monocytes
|
| IL-12p35+p70
|
B-T21
|
855.120.000 |
Inhibits IL-12 induced IFNg synthesis on PHA activated lymphocytes
|
| IL-13
|
B-B13
|
855.140.000 |
Inhibits IL-13 induced proliferation on TF1 cell line
|
| IL-15
|
B-E29
|
855.220.000 |
Inhibits IL-15 induced proliferation on Kit 225 cell line
|
| IL-17A
|
B-B51
|
853.910.000 |
Inhibits the bioactivity of IL-17A on keratinocytes cell line HaCaT (measurement of defensin-2 production)
|
| IL-17F
|
B-F60
|
855.360.000 |
Neutralises the bioactivity of IL-17F on HT1080 cell line (measurement of IL-6 production)
|
| IL-1β
|
B-A15
|
855.010.000 |
Inhibits IL-1β induced proliferation on D10S murine cell line
|
| IL-2
|
B-G5
|
855.020.000 |
Inhibits IL-2 induced proliferation on Kit 225 cell line
|
| IL-23
|
B-Z23
|
853.920.000 |
Inhibits the bioactivity of rhIL-23 on mouse splenocytes C57BI/6 (measurement of mIL-17 or mIL-22 production)
|
| IL-6
|
B-E8
|
855.050.000 |
Inhibits IL-6 induced proliferation on XG1 cell line
|
| IL-8
|
B-K8
|
855.080.000 |
Inhibits IL-8 induced chemotaxis of human neutrophils
|
| NKp46
|
B-L46
|
855.490.000 |
Measured by the ability of the coated antibody to induce degranulation of activated NK cells and to enhance IFNγ secretion by non-activated NK cells
|
| Neurotensin
|
B-N6
|
857.040.000 |
Inhibits neurotensin binding to its receptor
|
| TNF alpha
|
B-C7
|
855.150.000 |
Inhibits TNFα induced cytotoxicity on U937 cells
|
